En la selección de artículos colaboró la Dra. Cristina
Fernández Barrantes
AMERICAN JOURNAL OF HEALTH SYSTEM PHARMACY
2020 77 (12)
1.
A multicenter quality improvement
initiative on the impact of pharmacists’ postdischarge follow-up toreduce medication-related
acute care episodes. Pág. 938-942.
2.
Evaluating the effects of a
multidisciplinary transition care management program on hospital readmissions.
Pág. 931-937.
3.
Effects of pharmacy interventions at
transitions of care on patient outcomes. Pág. 943-949.
4.
Evaluation of a multidisciplinary approach
to reduce internal medicine readmissions using a readmission prediction index.
Pág. 950-957.
5.
Improving transitions of care for
critically ill adult patients on pulmonary arterial hypertension medications. Pág.
958-965.
6. Pharmacist-led
transitions-of-care program reduces 30-day readmission rates for Medicare
patients in a large health system. Pág. 972-978.
AMERICAN JOURNAL OF HEALTH SYSTEM PHARMACY
2020 77 (11)
8.
Direct-acting oral anticoagulant use at
extremes of body weight: Literature review and recommendations. Pág. 865-876.
9.
Pharmacokinetics of linezolid for methicillin-resistant Staphylococcus
aureus pneumonia in an adult receiving extracorporeal membrane oxygenation
.Pág. 877-881.
10. Long-term stability of ready-to-use
1-mg/mL midazolam solution. Pág. 681-689.
11. Safety of
intravenous push administration of beta-lactams within a healthcare system.
Pág. 701-708.
AMERICAN JOURNAL OF HEALTH SYSTEM PHARMACY
2020 77 (10)
12. A
physician-pharmacist collaborative care model to prevent opioid misuse 771-780
13. Procalcitonin
in special patient populations: Guidance for antimicrobial therapy. Pág.
745-758.
14. Involvement
of pharmacist-reviewed urine cultures and sexually transmitted infections in
the emergency department reduces time to antimicrobial optimization. Pág. Supl
2. S54-S59.
COVID-19
AMERICAN JOURNAL OF HEALTH SYSTEM
PHARMACY
15.
Implementation of field hospital pharmacy
services during the COVID-19 pandemic.
17. COVID-19 pandemic preparedness: A
practical guide from an operational pharmacy perspective.
18. Pharmacy services at a temporary COVID-19
hospital in Wuhan, China.
19. Surviving the
surge: Evaluation of early impact of COVID-19 on inpatient pharmacy services at
a community teaching hospital.
20.
Minimizing pharmacotherapy-related healthcare
worker exposure to SARS-CoV-2.
23. Assessment of Evidence for COVID-19-Related Treatments: Updated
CURRENT
OPINION PHARMACOLOGY 2020 53
24. Potential of glucocorticoids to treat intestinal inflammation during
sepsis. Pág.1-7.
25. Impact of gut microbiota on neurogenesis and neurological diseases
during infancy. Pág. 33-37.
26. Anti-inflammatory glucocorticoid action: genomic insights and
emerging concepts. Pág. 35-44.
CURRENT
OPINION PHARMACOLOGY 2020 50
27. Endocannabinoid system and adult neurogenesis: a focused review.
Pág. 25-32.
NEW ENGLAND JOURNAL OF MEDICINE 2020 382 (23)
28. Enzalutamide and Survival in Nonmetastatic,Castration-Resistant
Prostate Cancer. Pág. 2197-2206
NEW ENGLAND JOURNAL OF MEDICINE 2020 382 (24)
29 .Compassionate Use of Remdesivir for Patients with Severe Covid-19
Pág. 2327-2336.
30. Disseminated Coccidioidomycosis Treated with Interferon-γ and
Dupilumab. Pág.2337-2336